Drugs / Low-Titer Group O Whole Blood
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05638581 Comparator | Jul 2023 → Dec 2026 expected | — | University of Alabama at Birmingham | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low-Titer Group O Whole Blood | “Low-Titer Group O Whole Blood (LTOWB) is an attractive alternative to CT” PMID 40753420 ↗ Aug 2025 |
| Known as | LTOWB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05638581 ↗ |
| Route | Intravenous | “administered intravenously or intraosseously” NCT05638581 ↗ |
| Route | Other | “administered intravenously or intraosseously” NCT05638581 ↗ |